Reversion of duck hepatitis B virus DNA replication in vivo following cessation of treatment with the nucleoside analogue ganciclovir
- 31 May 1995
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 27 (1-2) , 171-178
- https://doi.org/10.1016/0166-3542(94)00081-i
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Treatment of chronic hepatitis BJournal of Viral Hepatitis, 1994
- The Half-Life of Duck Hepatitis B Virus Supercoiled DNA in Congenitally Infected Primary Hepatocyte CulturesVirology, 1994
- Alterations in intrahepatic expression of duck hepatitis B viral markers with ganciclovir chemotherapyLiver International, 1994
- In vitro antiviral activity of penciclovir, a novel purine nucleoside, against duck hepatitis B virusAntimicrobial Agents and Chemotherapy, 1994
- Characterization of the antiviral effects of 2′ carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virusHepatology, 1994
- Combination antiviral therapy controls severe post-liver transplant recurrence of hepatitis B virus infectionJournal of Gastroenterology and Hepatology, 1993
- INHIBITION OF HBV DNA REPLICATION BY GANCICLOVIR IN PATIENTS WITH AIDSThe Lancet, 1989
- Virus-liver cell interactions in duck hepatitis B virus infectionGastroenterology, 1988
- Hepatitis B virus DNA forms in nuclear and cytoplasmic fractions of infected human liverVirology, 1984
- Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediatePublished by Elsevier ,1982